Markers of Bone Remodeling in Metastatic Bone Disease-Reference-Cited by-同舟云学术

Markers of Bone Remodeling in Metastatic Bone Disease

Published:2003-11-01 Issue:11 Volume:88 Page:5059-5075
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Fohr Berthold¹,Dunstan Colin R.²,Seibel Markus J.²

Affiliation:

1. Department of Medicine (B.F.), University of Heidelberg, D-69117 Heidelberg, Germany; and Bone Research Program, ANZAC Research Institute

2. Department of Endocrinology, Concord Hospital Medical Centre (C.R.D., M.J.S.), University of Sydney, Sydney 2139, New South Wales, Australia

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/88/11/5059/9058152/jcem5059.pdf

Reference169 articles.

1. The anatomy and pathways of skeletal metastases;Galasco;In: Weiss L, Gilbert AH, eds. Bone metastases. Boston: GK Hall;,1981

2. Clinical aspects of bone metastases;Rubens;In: Body J-J, ed. Tumor bone diseases and osteoporosis in cancer patients. New York: Marcel Dekker Inc.;,2000

3. Pathogenesis of osteoblastic metastases;Goltzman;In: Body JJ, ed. Tumor bone diseases and osteoporosis in cancer patients. New York: Marcel Dekker Inc.;,2000

4. Markers of bone turnover in prostate cancer

5. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.;Taube;Bone,1994

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics, Current Treatment Options, Potential Mechanisms, Biomarkers, and Therapeutic Targets in Avascular Necrosis of Femoral Head;Medical Principles and Practice;2024-08-21

2. Value of procollagen type I N-terminal propeptide (P1NP) as a bone formation marker;Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie;2023-09-19

3. 症例報告：アジアゾウ（<i>Elephas maximus</i>）の子ゾウ2頭における離乳前後の血中骨代謝マーカー値;Japanese Journal of Zoo and Wildlife Medicine;2023-09-01

4. A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma;Cancer Research Communications;2023-06-08

5. Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice;Brain, Behavior, and Immunity;2023-05